PUBLISHER: The Business Research Company | PRODUCT CODE: 1821630
PUBLISHER: The Business Research Company | PRODUCT CODE: 1821630
Electrophoresis reagents are specifically formulated substances or mixtures designed to streamline the separation and analysis of samples during electrophoretic processes. They play a critical role in isolating biological molecules like proteins and DNA from cells, facilitating their examination and separation within electrophoresis.
The primary constituents of electrophoresis reagents comprise gels (such as polyacrylamide, starch, and agarose), buffers (like TAE buffer, TBE buffer, and others), dyes (including ETBR, SYBR, bromophenol blue, and similar compounds), and additional supporting reagents. Gels, synthesized through free-radical polymerization of bis-acrylamide and acrylamide, form the matrix for electrophoretic separation, particularly polyacrylamide gels utilized in protein separation via gel electrophoresis. Electrophoresis techniques, namely capillary electrophoresis and gel electrophoresis are employed for DNA and RNA analysis as well as protein analysis. End-users of these reagents span pharmaceutical and biotechnology companies, hospitals, diagnostic laboratories, academic and research institutions, and various other entities involved in molecular analysis and research.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.
The electrophoresis reagents market research report is one of a series of new reports from The Business Research Company that provides electrophoresis reagents market statistics, including electrophoresis reagents industry global market size, regional shares, competitors with an electrophoresis reagents market share, detailed electrophoresis reagents market segments, market trends and opportunities, and any further data you may need to thrive in the electrophoresis reagents industry. This electrophoresis reagents market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The electrophoresis reagents market size has grown steadily in recent years. It will grow from $1.31 billion in 2024 to $1.37 billion in 2025 at a compound annual growth rate (CAGR) of 4.9%. The growth in the historic period can be attributed to increased demand for clinical diagnostics, introduction of innovative reagents, growing academic and research institutes, clinical research and biomarker discovery, global market expansion.
The electrophoresis reagents market size is expected to see strong growth in the next few years. It will grow to $1.86 billion in 2029 at a compound annual growth rate (CAGR) of 7.9%. The growth in the forecast period can be attributed to expansion of point-of-care testing, shift towards capillary electrophoresis, focus on sustainable reagent formulations, demand for high-throughput analysis, advancements in microfluidic electrophoresis. Major trends in the forecast period include technological advancements in electrophoresis techniques, adoption of next-generation sequencing (NGS), demand for high-throughput techniques, strategic collaborations and partnerships, integration of artificial intelligence (AI) in data analysis, customization and compatibility.
The forecast of 7.9% growth over the next five years reflects a slight reduction of 0.2% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Trade tensions could hinder U.S. adoption of advanced diagnostic techniques by inflating prices of electrophoresis reagents developed in Sweden and China, resulting in slower test processing and higher pathology department costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.
The rapidly growing geriatric population is anticipated to drive the expansion of the electrophoresis reagent market. The geriatric population refers to individuals aged 60 years and older within the total population. Hemoglobin electrophoresis, a test that assesses hemoglobin levels, is commonly utilized to diagnose anemia, sickle cell disease, and other hemoglobin-related disorders. For example, in January 2024, a report by the Pew Research Center, a US-based nonpartisan fact tank, indicated that the geriatric population is projected to increase from 0.2% in 2024 to 0.5% by 2054. As a result, the rising geriatric population is fueling the growth of the electrophoresis reagent market.
The growing demand in hospitals is expected to further propel the electrophoresis reagent market. Hospitals are large, specialized healthcare institutions that offer a broad range of medical services, treatment, and care for individuals who are ill or injured. Electrophoresis reagents play a vital role in diagnostics, research, and the detection and monitoring of various medical conditions within hospitals, contributing to advancements in patient care and medical knowledge. For instance, in August 2023, Interweave Textiles Limited, a UK-based textile manufacturing company, reported that there are 1,148 hospitals in the UK. Therefore, the increasing number of hospitals is driving the growth of the electrophoresis reagent market.
Innovation in product development has emerged as a notable trend reshaping the electrophoresis reagents market. Key companies within the sector are focused on creating novel products to maintain their market standing. For instance, in February 2022, Kemira Oyj, a Finland-based chemical industry company, introduced biomass-balanced polyacrylamide. This polymer, possessing similar technical properties to its conventional counterpart, finds utility in various industries such as energy, demanding paper applications, water treatment, and other water-intensive sectors.
Major companies in the electrophoresis reagents market are focusing on developing innovative products, such as ionic calixarene-based detergents/surfactants, to boost their revenues. An ionic calixarene-based detergent/surfactant is a specialized surfactant derived from calixarene compounds, known for its amphiphilic properties. For example, in September 2022, Amerigo Scientific, a US-based distribution company serving the biomedical and life science research sectors, introduced the CALX8 Reagent. CALX8 Reagent is an ionic calixarene-based detergent/surfactant specifically designed for membrane protein research. It contains three polar carboxylic groups and an octyl chain, making it highly effective in solubilizing and stabilizing membrane proteins while preserving their structural integrity. This reagent is particularly beneficial in various stages of membrane protein studies, including extraction, stabilization, isolation, and crystallization. This innovation aims to enhance life science research and applications by improving the efficiency of laboratory processes.
In September 2023, Agilent Technologies, a US-based provider of scientific instruments, software, services, and consumables for laboratories, partnered with the National Cancer Institute. This partnership aims to enhance the capabilities of Agilent's electrophoresis technology for cancer research. The collaboration seeks to leverage advanced electrophoresis techniques to improve the analysis of cancer biomarkers, which is essential for advancing diagnostic and treatment strategies. The National Cancer Institute is the principal federal agency in the United States dedicated to cancer research.
Major companies operating in the electrophoresis reagents market are Thermo Fisher Scientific Inc., Sigma-Aldrich Corporation, Bio-Rad Laboratories Inc., Agilent Technologies Inc., Lonza Group Ltd., Takara Bio Inc., Sebia Group, The Merck Group, Cytiva, Promega Corporation, Helena Laboratories Corporation, Randox Laboratories Limited, Qiagen NV, Hoefer Inc., VWR International GmbH, anamed Elektrophorese GmbH, Alfa Aesar, GenScript Corp., Zymo Research Corp., Omega Bio-tek Inc., Norgen Biotek Corp., Eurofins Genomics LLC
North America was the largest region in the electrophoresis reagents market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the electrophoresis reagents market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the electrophoresis reagents market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The electrophoresis reagents market consists of sales of electrophoresis reagents that are used for electrophoretic separation and sample analysis. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Electrophoresis Reagents Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on electrophoresis reagents market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for electrophoresis reagents ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The electrophoresis reagents market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.